KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Gains from Investment Securities (2016 - 2025)

Chemed (CHE) has 16 years of Gains from Investment Securities data on record, last reported at $14000.0 in Q4 2024.

  • For Q4 2024, Gains from Investment Securities fell 99.66% year-over-year to $14000.0; the TTM value through Dec 2024 reached $295000.0, down 96.91%, while the annual FY2024 figure was $295000.0, 96.91% down from the prior year.
  • Gains from Investment Securities reached $14000.0 in Q4 2024 per CHE's latest filing, down from $16000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $19.2 million in Q3 2020 and bottomed at -$17.9 million in Q4 2020.
  • Average Gains from Investment Securities over 5 years is $576900.0, with a median of $138500.0 recorded in 2020.
  • Peak YoY movement for Gains from Investment Securities: surged 4492.36% in 2021, then tumbled 1657.51% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at -$17.9 million in 2020, then soared by 104.17% to $746000.0 in 2021, then crashed by 1657.51% to -$11.6 million in 2022, then soared by 135.38% to $4.1 million in 2023, then tumbled by 99.66% to $14000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $14000.0 in Q4 2024, $16000.0 in Q3 2024, and $257000.0 in Q2 2024.